| 1 |
31672485 | PSA time to nadir as a prognostic factor of first-line docetaxel treatment in castration-resistant prostate cancer: Multicenter validation in patients from the Chinese Prostate Cancer Consortium. | 2020 Jan |
1 |
| 2 |
31126725 | Prostate-specific Antigen Bounce After Stereotactic Body Radiotherapy for Prostate Cancer: A Pooled Analysis of Four Prospective Trials. | 2019 Sep |
2 |
| 3 |
29756298 | Primary whole-gland ablation for localized prostate cancer with high-intensity focused ultrasound: The important predictors of biochemical recurrence. | 2018 Jun |
3 |
| 4 |
30085076 | Clinical features of prostate-specific antigen bounce after 125I brachytherapy for prostate cancer. | 2018 Sep 1 |
2 |
| 5 |
26089252 | Clinical outcomes and nadir prostate-specific antigen (PSA) according to initial PSA levels in primary androgen deprivation therapy for metastatic prostate cancer. | 2016 Mar |
1 |
| 6 |
26867889 | Image Guided Hypofractionated Postprostatectomy Intensity Modulated Radiation Therapy for Prostate Cancer. | 2016 Mar 1 |
2 |
| 7 |
25444980 | Ultrasensitive prostate specific antigen and its role after radical prostatectomy: a systematic review. | 2015 May |
1 |
| 8 |
24372730 | Salvage partial brachytherapy for prostate cancer recurrence after primary brachytherapy. | 2014 Jun |
1 |
| 9 |
16890642 | The interpretation of serum prostate specific antigen in men receiving 5alpha-reductase inhibitors: a review and clinical recommendations. | 2006 Sep |
1 |
| 10 |
16398402 | Usefulness of prostate-specific antigen nadir as predictor of androgen-independent progression of metastatic prostate cancer. | 2005 Oct-Dec |
2 |
| 11 |
12023133 | Posttreatment prostate-specific antigen nadir highly predictive of distant failure and death from prostate cancer. | 2002 Jun 1 |
3 |
| 12 |
10081869 | Prostate specific antigen nadir achieved by men apparently cured of prostate cancer by radiotherapy. | 1999 Apr |
1 |
| 13 |
10526285 | Defining biochemical cure for prostate carcinoma patients treated with external beam radiation therapy. | 1999 Oct 15 |
1 |
| 14 |
9779716 | Predictors of improved outcome for patients with localized prostate cancer treated with neoadjuvant androgen ablation therapy and three-dimensional conformal radiotherapy. | 1998 Oct |
2 |
| 15 |
9126238 | Prostate-specific antigen after radiation therapy. Prognosis by pretreatment level and post-treatment nadir. | 1997 May |
1 |
| 16 |
8683700 | Prostate specific antigen nadir following external beam radiation therapy for clinically localized prostate cancer: the relationship between nadir level and disease-free survival. | 1996 Aug |
2 |
| 17 |
7523340 | Serum prostate-specific antigen after radiation therapy for clinically localized prostate cancer: prognostic implications. | 1994 Sep 30 |
1 |
| 18 |
7690018 | Prostate-specific antigen density: a new prognostic indicator for prostate cancer. | 1993 Sep 1 |
2 |